NCT07028047View on ClinicalTrials.gov

Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions
Advanced EBV-positive Malignant Solid Tumors
Interventions
BIOLOGICAL

WGc-043 Injection

WGc-043 Injection, intramuscular injection

All Listed Sponsors
lead

Sun Yat-sen University

OTHER